Medtronic secures permanent CPT codes for urinary incontinence and hypertension devices
The American Medical Association granted Medtronic permanent Category I CPT codes for its Altaviva tibial neuromodulation implant and the Symplicity Spyral renal denervation system. The codes replace the prior Category III designations and will become active in January 2028. Medtronic said the approvals reflect strong clinical data and growing physician use. The devices target urge urinary incontinence and uncontrolled high blood pressure, respectively.
Why it matters
Medtronic notes that Category I status can aid physician billing and influence commercial payer policies, potentially expanding market uptake of both products. The company expects the new codes to support longer‑term revenue growth for the two technologies.
Key facts
- 1The AMA approved Category I CPT codes for Altaviva and Symplicity Spyral, effective January 2028. news.medtronic.com
- 2Altaviva received FDA clearance in September 2025 for treating urge urinary incontinence. news.medtronic.com
- 3Symplicity Spyral obtained Medicare coverage in October 2025 for renal denervation to lower blood pressure. news.medtronic.com
- 4Lindsay Bockstedt, vice president of health economics, policy, and reimbursement at Medtronic, said the approvals reflect robust clinical evidence and physician adoption. news.medtronic.com
- 5Category I CPT codes are permanent and indicate procedures that are well established and widely performed in the United States. investing.com
Summary written by AlphAI from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.